Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of AR134057A2publicationCriticalpatent/AR134057A2/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La presente invención se relaciona con una formulación farmacéutica acuosa que comprende 1-(4-{[4-(dimetilamino)piperidin-1-il]carbonil}enil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)enil]urea, o una sal farmacéuticamente aceptable de la misma, que es una solución transparente. Tal formulación es particularmente adecuada para administración intravenosa o parenteral a un paciente.
ARP240102717A2014-12-172024-10-04Composición farmacéutica en solución acuosa
AR134057A2
(es)